Pfizer

Could This Move by Moderna Cost Pfizer Billions?
Motley Fool
Sun, 08/28/22 - 10:06 pm
Pfizer
BioNTech
vaccines
patents
MRNA
COVID-19
Moderna sues Pfizer, BioNTech over COVID-19 vaccine technology
BioPharma Dive
Fri, 08/26/22 - 12:20 pm
Moderna Therapeutics
Pfizer
BioNTech
MRNA
legal
COVID-19
vaccines
Revealed: which pharma companies leading the way in artificial intelligence
Clinical Trials Arena
Fri, 08/26/22 - 10:37 am
artificial intelligence
Pfizer
Novartis
AstraZeneca
Johnson & Johnson
Bristol Myers Squibb
Takeda
GSK
Bayer
Astellas
Pfizer heads to the FDA with an early lead over rivals in the $10B RSV vaccine market
Endpoints
Thu, 08/25/22 - 11:27 am
Pfizer
vaccines
RSV
RSVpreF
Pfizer's Paxlovid only helped seniors avoid hospitalization and death, new NEJM study finds
Endpoints
Wed, 08/24/22 - 10:42 pm
Paxlovid
Pfizer
Seniors
COVID-19
Moderna follows Pfizer in asking FDA to approve updated COVID shot
BioPharma Dive
Wed, 08/24/22 - 10:48 am
Moderna
Pfizer
FDA
COVID-19
vaccines
boosters
Johnson & Johnson lost to Pfizer in bidding war for Global Blood Therapeutics: Bloomberg
Fierce Pharma
Wed, 08/24/22 - 10:34 am
Pfizer
JNJ
M&A
Global Blood Therapeutics
Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age
BioSpace
Tue, 08/23/22 - 10:24 am
Pfizer
BioNTech
vaccines
COVID-19
pediatric
Pfizer, BioNTech submit omicron booster for FDA clearance
BioPharma Dive
Mon, 08/22/22 - 08:29 pm
Pfizer
BioNTech
FDA
COVID-19
vaccines
boosters
Omicron variant
Canada OKs Pfizer COVID-19 Booster For Kids Aged 5-11 Years
Yahoo/Benzinga
Mon, 08/22/22 - 09:47 am
Canada
Pfizer
BioNTech
COVID-19
vaccines
pediatric
boosters
Pfizer discontinues development of dilated cardiomyopathy drug emprumapimod
Clinical Trials Arena
Thu, 08/18/22 - 11:14 pm
Pfizer
dilated cardiomyopathy
clinical trials
emprumapimod
With Pfizer, AZ and Merck leading the way, Big Pharma weathered the economic storm in Q2
Fierce Pharma
Mon, 08/15/22 - 10:35 am
earnings
Pfizer
AstraZeneca
Merck
Big Pharma
inflation
supply chain
Ukraine
pandemic
COVID-19
Pfizer CEO Bourla shows mild symptoms after testing positive for COVID
Reuters
Mon, 08/15/22 - 10:31 am
Pfizer
Albert Bourla
Pharma CEOs
COVID-19
vaccines
Pfizer's 20-valent pneumococcal vaccine hits goal in infant trial, teeing up 2022 approval filing
Fierce Biotech
Fri, 08/12/22 - 10:16 am
Pfizer
vaccines
Prevnar 20
FDA
infants
clinical trials
pneumococcal disease
In warranty program, Pfizer will refund up to $50K for patients who discontinue use of rare disease drug
Fierce Pharma
Wed, 08/10/22 - 12:04 am
Pfizer
Xalkori
warranty
Panzyga
CIPD
Workers at Pfizer Australian manufacturing site the latest to walk out in labor dispute protests
Endpoints
Tue, 08/9/22 - 11:52 pm
Pfizer
Australia
labor disputes
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
BioSpace
Tue, 08/9/22 - 06:27 am
Pfizer
Valneva
clinical trials
vaccines
Lyme disease
VLA15
Pfizer and Myovant’s endometriosis pain drug Myfembree gets another FDA nod
Endpoints
Mon, 08/8/22 - 11:28 pm
Pfizer
Myovant
FDA
Myfembree
endometriosis
Pfizer buys sickle cell drugmaker Global Blood for $5.4B
BioPharma Dive
Mon, 08/8/22 - 10:29 am
Pfizer
Global Blood Therapeutics
M&A
sickle cell disease
Oxbryta
Pfizer, riding high on COVID windfall, eyes $5B play for Global Blood Therapeutics
Fierce Pharma
Sun, 08/7/22 - 11:27 pm
Pfizer
Global Blood Therapeutics
M&A
Oxbryta

Pages